Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose-response trial. - West A; Chaudhuri N; Barczyk A; Wilsher ML; Hopkins P; Glaspole I; Corte TJ; Šterclová M; Veale A; Jassem E; Wijsenbeek MS; Grainge C; et al. (Thorax, 2023)